Cite
HARVARD Citation
Calvo Moya, M. et al. (n.d.). P533 Adalimumab 80mg every other week in inflammatory bowel disease: Treatment intensification outcomes in real life clinical practice. Journal of Crohn's and colitis. pp. S507-S509. [Online].